SCHEMBL4116337

SCHEMBL4116337

c1ccc(COc2cc(-c3cncnc3)nc(N3CCOCC3)n2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.60
PIK3CA P42336 9/20 0.55
PIK3CB P42338 1/20 0.55
PIK3CG P48736 1/20 0.55
ALDH1A1 P00352 4/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALOX15 P16050 2/20 0.46
USP2 O75604 1/20 0.46
ATM Q13315 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
AKT1 P31749 1/20 0.45
HSD17B10 Q99714 2/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
TSHR P16473 2/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13848198 0.88 PIK3CA (0.60) CYP11B2PIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL13848204 0.81 PIK3CA (0.55) CYP11B2PIK3CAPIK3CBPIK3CGAKT1
SCHEMBL3990390 0.79 CYP11B2 (0.65) CYP11B2PIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3990409 0.78 PIK3CA (0.58) PIK3CAPIK3CBPIK3CGAKT1MAP3K12
SCHEMBL3989949 0.77 PIK3CA (0.42) CYP11B2PIK3CAPIK3CBPIK3CGL3MBTL1
SCHEMBL3993009 0.77 PIK3CA (0.62) CYP11B2PIK3CAPIK3CBPIK3CGAKT1
SCHEMBL13848159 0.77 PIK3CA (0.52) CYP11B2PIK3CAPIK3CBPIK3CGMAP3K12
SCHEMBL4117117 0.76 HTR1A (0.47) PIK3CAPIK3CBPIK3CGALDH1A1SMN1; SMN2
SCHEMBL13848128 0.76 PIK3CA (0.54) PIK3CAPIK3CBPIK3CGAKT1LMNA
SCHEMBL18489956 0.76 CYP11B2 (1.00) CYP11B2ALDH1A1SMN1; SMN2ALOX15USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009066084-A1 2 -MORPHOLINOPYRIMIDINES AND THEIR USE AS PI3 KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-28 WO claimed